☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
exercise
Sanofi and Alnylam Exercise Research and Option Phase Collaboration for its 2014 Deal
April 8, 2019
Circassia Plans to Exercise Option for the US Commercialization Rights for Tudorza (aclidinium) From AstraZeneca
December 12, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
